Featured

Opioid Addiction During a Public Health Crisis

By: Anjali Rana, PharmD Candidate c/o 2025 and Katharine Russo, PharmD               The Coronavirus disease 2019 (COVID-19) pandemic continues to…

5 years ago

Ranitidine (Zantac®) Making a Comeback

By: Mandy Zheng, PharmD Candidate c/o 2024               “Where can I find Zantac?”. From April 2020 to May 2021, the…

5 years ago

Potentially Life-Threatening Interactions Between Newer Smartphones and ICDs

By: Richa Tamakuwala, PharmD Candidate c/o 2022               There has been a dramatic rise in the number of patients with…

5 years ago

CAR T-cell therapy for Multiple Myeloma

By: Lyana Sayilar, PharmD Candidate c/o 2022               Multiple myeloma is characterized by an accumulation of abnormal plasma cells in…

5 years ago

Dravet’s Syndrome and a Novel Antiepileptic Drug: Cannabidiol (Epidiolex®)

By: Jason Ifeanyi, PharmD Candidate c/o 2022               Epilepsy is a highly prevalent neurological disorder caused by unusual nerve cell…

5 years ago

Pharmaceutical Breakthrough for the Treatment of Duchenne Muscular Dystrophy

By: Rubab Hassan, PharmD Candidate c/o 2022              Duchenne muscular dystrophy (DMD) is a genetic disorder that causes muscle degeneration…

5 years ago

Emerging Frontiers in Multiple Myeloma Pharmacotherapy

By: Nishanth Viswanath, PharmD Candidate c/o 2022              Multiple myeloma (MM)  is a hematological malignancy characterized by an accumulation and…

5 years ago

Desmopressin Challenge for Von Willebrand’s Disease in the Setting of Myasthenia Gravis

By: Oluwafemi Popoola, PharmD Candidate c/o 2021, SUNY Binghamton School of Pharmacy & Pharmaceutical Sciences              A patient with past…

5 years ago

FDA approves Vibegron (Gemtesa®) for the Treatment of Patients with Symptoms of Overactive Bladder

By: Arya Firoozan, PharmD Candidate c/o 2023              Overactive bladder (OAB) is a condition that causes a sudden and frequent…

5 years ago

Correlation of Salt-Intake and Hypertension

By: Jordan Plair, PharmD Candidate c/o 2022 and Marina Beshara, PharmD Candidate c/o 2022              While the focus over the…

5 years ago